Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 170
News
News | 31 July 2021

Zydus Wellness Q1FY22 consolidated net profit at Rs. 130.80 Cr

The company posted net profit of Rs.89.20 crores for the period ended June 30, 2020.

News
News | 30 July 2021

Eris Lifesciences planning new manufacturing facility

The new greenfield manufacturing facility will be operated alongside the Guwahati facility as a parallel unit thereby helping mitigate the risks of a single-location operation

News
News | 29 July 2021

RPG Life Sciences Q1FY22 PAT surges to Rs. 13.58 Cr

The company posted net profit of Rs.9.06 crores for the period ended June 30, 2020.

News
News | 29 July 2021

Astec Lifesciences 1FY22 consolidated PAT at Rs. 12.98 Cr

The company posted net profit of Rs.16.18 crores for the period ended June 30, 2020.

News
News | 29 July 2021

Pfizer posts Q1FY22 PAT of Rs. 199.91 Cr

The company posted net profit of Rs.124.45 crores for the period ended June 30, 2020.

News
News | 28 July 2021

Aarti Drugs posts Q1FY22 consolidated PAT at Rs. 48.81 Cr

The company posted net profit f Rs.85.45 crores for the period ended June 30, 2020.

News
News | 28 July 2021

Granules India Q1FY22 consolidated net profit at Rs. 120.20 Cr

The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.

News
News | 28 July 2021

Bharat Immunologicals and Biologicals Corporation Q1FY22 net profit at Rs. 1.92 Cr

The company reported total income Rs.18.57 crores during the period ended June 30, 2020.

News
News | 28 July 2021

Torrent Pharmaceuticals Q1FY22 consolidated PAT up at Rs. 330 Cr

The company posted net profit of Rs.321 crores for the period ended June 30, 2020.

News
News | 28 July 2021

Dr. Reddy's Laboratories Ltd Q1FY22 consolidated PAT at Rs. 380.4 Cr

The company posted net profit of Rs.594.6 crores for the period ended June 30, 2020.

News
News | 28 July 2021

Morepen Laboratories posts Q1FY22 consolidated PAT of Rs. 30.47 Cr

The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.

News
News | 28 July 2021

Morepen to start Sputnik V Vaccine commercial production in 4-6 weeks

The first six batches are being shipped to the Gamaleya Center, Moscow for the quality approval

News
News | 27 July 2021

Sun Pharma signs Cassiopea for license and supply agreements

Winlevi has been approved by the United States FDA as a novel drug with a unique mechanism of action for the topical treatment of acne in patients 12 years and older

News
News | 27 July 2021

Kilitch starts injectables production at Ethiopia

The Cephalosporin Injectables plant has a total capacity of 26.4 million vials per year while Ethiopia is having a demand for 16 million vials

News
News | 27 July 2021

Sun Pharma Advanced Research Company Q1FY22 loss at Rs. 61.37 Cr

The company posted net loss of Rs.56.69 crores for the period ended June 30, 2020.

News
News | 27 July 2021

GlaxoSmithKline delivers 19% revenue growth for Q1 FY22

The company has decided to transfer our rights in relation to the lodex and Ostocalcium brands to GlaxoSmithKline Asia Private Limited

News
News | 27 July 2021

Alembic Pharmaceuticals Q1FY22 net slides to Rs. 164.52 Cr

The US business faced price erosion due to increased competition.

News
News | 27 July 2021

Lasa production to commence in couple of weeks

The company is confident of commencing production at both Mahad and Chiplun units soon

News
News | 27 July 2021

Biocon Biologics partners Adagio to manufacture antibody for COVID-19

ADG20, a novel monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses

News
News | 26 July 2021

Panacea Biotec posts consolidated loss of Rs. 57.35 Cr in Q1FY22

It posted net (loss) of Rs.(34.13) crores for the period ended June 30, 2020.

Startup

Digitization